Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Documentation of Dispensed Quantities – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Documentation of Dispensed Quantities – V 2.0

Standard Operating Procedure for Documentation of Dispensed Quantities


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/109/2025
Supersedes SOP/SIM/109/2022
Page No. Page 1 of 10
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define the procedure for documenting the quantities of raw materials dispensed for each batch in sterile injectable manufacturing, ensuring traceability and compliance with cGMP requirements.

2. Scope

This procedure is applicable to all raw materials (APIs and excipients) dispensed in the dispensing area for batch manufacturing of

sterile injectable products.

3. Responsibilities

  • Dispensing Operator: Record dispensed quantities, weights, date, and time in real-time on the dispensing sheet.
  • Production Supervisor: Review dispensing documentation before releasing materials to manufacturing.
  • QA Personnel: Verify and approve all records and ensure compliance with the documentation SOP.
See also  Sterile Injectable Manufacturing: SOP for Equipment Sterilization and Assembly Validation - V 2.0

4. Accountability

The Head of Production and Head of QA are accountable for ensuring adherence to this SOP.

5. Procedure

5.1 Documentation in Dispensing Sheets

  1. Each material dispensed must be documented in the Dispensing Sheet (Annexure-1) with the following information:
    • Material Name and Code
    • Batch Number of Raw Material
    • Required Quantity
    • Actual Dispensed Quantity
    • Container Number and Seal Status
    • Date, Time, Signature of Dispensing Operator
  2. All weights must be recorded to the appropriate decimal precision as per weighing balance specifications.

5.2 Correction of Entries

  • Do not overwrite. Use a single strike-through and initial any correction.
  • Mention reason for correction if the deviation is significant (e.g., difference >1%).
See also  Sterile Injectable Manufacturing: SOP for Formulation Development of Intraosseous Injections - V 2.0

5.3 Verification and Archiving

  1. QA verifies and signs off the documentation against the approved BMR.
  2. Completed dispensing records are filed with the batch manufacturing record (BMR).
  3. Electronic records, if used, must be backed up and protected by password-controlled access.

6. Abbreviations

  • API: Active Pharmaceutical Ingredient
  • BMR: Batch Manufacturing Record
  • cGMP: current Good Manufacturing Practices
  • QA: Quality Assurance

7. Documents

  1. Dispensing Sheet – Annexure-1
  2. Dispensing Logbook – Annexure-2
  3. Material Usage Summary – Annexure-3

8. References

  • 21 CFR Part 211 – cGMP for Finished Pharmaceuticals
  • Company Quality System Manual

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Dispensing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance
See also  Quality Assurance: SOP for Risk Mitigation Strategies in QA Activities - V 2.0

11. Annexures

Annexure-1: Dispensing Sheet

Material Name Batch No. Qty Required Qty Dispensed Container No. Date Operator
Sodium Chloride SC2201 10.00 kg 10.05 kg 1 18/06/2025 R. Verma

Annexure-2: Dispensing Logbook

Chronological record of all dispensing activities per day per shift with signatures.

Annexure-3: Material Usage Summary

Summary of materials dispensed, used, returned, and reconciled for the batch.

Revision History

Revision Date Revision No. Details Reason Approved By
10/01/2022 1.0 Initial version New SOP implementation QA Head
18/06/2025 2.0 Expanded documentation requirements and digital record inclusion GMP Update QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Elixir Department: SOP for Vortex Mixer Operation for Lab Batches – V 2.0
Next Post: Regulatory Impact of Vague Terms Like ‘As Required’ in SOPs

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version